Lobbying Filing Details

Total Spending

$60,000

Activities

1

Lobbyists

1

Gov't Entities

5

Filing Information
Filing UUID:
d9a3bd4a-35d0-4e12-a81f-d477bb0bd5a6
Type:
Q2 - 2nd Quarter - Report
Period:
2023 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 19, 2023 at 1:12 AM
Income:
$0
Expenses:
$60,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: John Allen
Registrant
INOVIO PHARMACEUTICALS, INC.
Plymouth Meeting, Pennsylvania
Client
INOVIO PHARMACEUTICALS, INC.

Biotechnology company

Pennsylvania, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Issues related to Recurrent Respiratory Papillomatosis (RRP), an HPV associated disease; Issues related to the Orphan Drug Act and orphan drug destination; Issues related to the Orphan Drug Tax Credit; Issues related to Accelerated Approval reforms and accelerated approval pathway at FDA and decentralized trials; Issues related to CMS IRA implementation and small biotech exemption; Issues related to the Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Next Generation COVID-19 vaccines and boosters; Issues related to ASPR/BARDA and manufacturing of pan-coronavirus vaccines and boosters; Issues related to Oncology and HPV cancers and other associated diseases; Issues related to medical devices and cybersecurity issues; Issues related to Transitional Coverages of Emerging Technologies (TCET) and medical devices; Issues related to FY2024 Labor, Health and Human Services and Education Annual Appropriations; DNA Medicines Platform Technology awareness

Lobbyists (1)
  • MS. COOKAB HASHEMI
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Defense, Dept of (DOD)
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved November 17, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.